Yes, depression is a medical illness. It is classified as a mood disorder by the American Psychiatric Association, diagnosed using standardized clinical criteria, and associated with measurable changes in brain structure, brain chemistry, immune function, and stress hormones. Roughly 5.7% of adults worldwide live with depression, making it one of the most common medical conditions on the planet.
That classification matters because it shapes how depression is understood and treated. It is not a character flaw, a sign of weakness, or simply feeling sad after a bad week. It is a condition with identifiable biological underpinnings, a formal diagnostic process, and effective treatments. Here’s what makes it qualify as a genuine illness.
How Depression Differs From Normal Sadness
Sadness is a universal human emotion. It shows up after a breakup, a job loss, the death of someone you love. It typically fades on its own as circumstances change or time passes. Depression does not work this way.
A clinical diagnosis of major depressive disorder requires at least five specific symptoms present nearly every day for two weeks or longer, representing a clear change from how you normally function. At least one of those symptoms must be either a persistently depressed mood or a marked loss of interest or pleasure in activities you used to enjoy. The full list of nine recognized symptoms includes significant changes in weight or appetite, insomnia or excessive sleeping, physical restlessness or a noticeable slowing down, constant fatigue, feelings of worthlessness or inappropriate guilt, difficulty thinking or concentrating, and recurrent thoughts of death or suicide.
The key distinction is duration, severity, and functional impact. Sadness comes and goes. Depression persists, colors nearly everything, and interferes with your ability to work, maintain relationships, or handle daily tasks. When a sad mood lasts two weeks or more and disrupts normal everyday functioning, the line has been crossed from a passing emotion into a diagnosable medical condition.
What Happens in the Brain
Depression involves real, measurable changes in brain chemistry. The most studied theory centers on three chemical messengers: serotonin, norepinephrine, and dopamine. In people with depression, the production, signaling, or recycling of these chemicals is disrupted. Serotonin synthesis can be reduced, and the receptors that regulate serotonin function show decreased availability across multiple brain areas. Dopamine turnover is consistently lower, based on measurements of its byproducts in spinal fluid. Norepinephrine metabolism is altered, with changes detected in the brain region (the locus coeruleus) responsible for producing it.
Other brain chemicals are involved too. GABA, the brain’s primary calming signal, is found at reduced concentrations in the prefrontal and occipital cortex during acute depression. Glutamate, the brain’s main excitatory signal, also shows abnormal levels. The fact that a glutamate-blocking drug (ketamine) can produce rapid antidepressant effects within hours has strengthened the case that these chemical imbalances are directly tied to depressive symptoms.
Beyond chemistry, the physical structure of the brain changes. Brain imaging studies, confirmed by multiple meta-analyses, show that the hippocampus (a region critical for memory and emotional regulation) is smaller in people with depression compared to healthy controls. This shrinkage is more pronounced in people over 40, those with severe depression, or those who have experienced multiple episodes. The prefrontal cortex, which governs decision-making and emotional control, also shows significant reductions in thickness and gray matter volume. These structural changes are associated with the difficulty concentrating, the emotional flatness, and the poor decision-making that characterize the disorder. Encouragingly, some of these brain changes partially reverse with treatment.
The Role of Stress Hormones and Inflammation
Depression also involves the body’s stress response system. Chronic stress activates what’s known as the HPA axis, a communication loop between the brain and adrenal glands. In depression, this system can become overactive, flooding the brain with stress hormones called glucocorticoids. These hormones bind to receptors in the hippocampus, and over time, this contributes to the hippocampal shrinkage seen on brain scans.
There is also a strong inflammatory component. A large meta-analysis comparing over 5,000 patients with depression to a similar number of healthy controls found significantly elevated levels of multiple inflammatory markers. C-reactive protein (a general marker of inflammation in the body), tumor necrosis factor alpha, and several immune signaling molecules called interleukins were all reliably higher in the depression group. Some of these markers showed notably reduced variability among patients, suggesting that inflammation is not just an occasional finding but a consistent biological feature of the condition. This is one reason researchers now consider depression partly an inflammatory disease, not just a brain chemistry problem.
Genetics Play a Significant Role
Depression runs in families, and twin studies have quantified just how much of the risk is inherited. The largest Swedish national twin study, which remains one of the most cited in the field, estimated heritability at 42% in women and 29% in men. That means roughly a third to nearly half of your susceptibility to depression comes from your genes, with the remainder driven by life experiences and environmental factors.
Some of these genetic risk factors are sex-specific, which helps explain why depression is diagnosed more often in women (6.9% of women globally versus 4.6% of men, according to the World Health Organization). Specific gene variants have been identified that impair the brain’s ability to produce serotonin, including mutations in the enzyme responsible for serotonin synthesis. No single gene causes depression, but the cumulative effect of many genetic variations can make one person substantially more vulnerable than another, even in similar life circumstances.
Why the “Illness” Label Matters
Calling depression an illness is not just a semantic choice. It has practical consequences for how people are treated, both medically and socially. When depression is framed as a personal failing or a matter of willpower, people delay seeking help, and those around them offer advice like “just cheer up” instead of support. When it is recognized as an illness with biological roots, it becomes something that can be evaluated, monitored, and treated like any other medical condition.
The diagnostic framework also ensures consistency. The DSM-5, the standard reference used in clinical settings, classifies several forms of depressive disorder, including major depressive disorder, persistent depressive disorder (a longer-lasting but sometimes less severe form), and depressive disorder caused by another medical condition. Each has defined criteria, which means two different clinicians evaluating the same patient should reach the same diagnosis. That kind of reliability is a hallmark of recognized medical conditions.
None of this means that life circumstances, relationships, trauma, and daily habits are irrelevant. They clearly matter, both as triggers and as part of recovery. But the same is true of heart disease, diabetes, and many other conditions no one hesitates to call illnesses. Depression involves the body, changes the brain, has a genetic basis, shows up on lab tests and imaging, responds to medical treatment, and impairs functioning. By every reasonable standard, it is an illness.